In pediatric patients presenting with moderate to severe asthma exacerbations, there is good evidence supporting the use of ipratropium bromide added to beta-agonists.
By Erica Hoe|2019-04-29T11:11:11-04:00April 29th, 2019|Comments Off on In pediatric patients presenting with moderate to severe asthma exacerbations, there is good evidence supporting the use of ipratropium bromide added to beta-agonists.
